PDPs build local capacity to perform research and strengthen health systems

 

PDPs have performed clinical research at more than 700 sites in 98 countries, mostly in LMICs. Through partnerships, training, infrastructure improvements, and the development of the next generation of researchers, disease experts, and scientific leaders, PDPs build sustainable platforms for research that better prepare countries to address emerging and future health issues and research questions. The infrastructure in many LMICs that is currently being used to operationalize local efforts to combat COVID-19 has been substantially developed through collaborative product development work with PDPs. Furthermore, the very products that PDPs develop often enhance the performance of health systems, for example, oral treatments that avoid hospitalization, and rapid diagnostics that enhance primary health care capacity to meet health needs and reduce costs.

 
Previous
Previous

PDPs save money and are a cost-effective way to save lives and grow economies

Next
Next

The products that PDPs develop are essential to achieve universal health coverage and the United Nations 2030 Sustainable Development Goals